Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Waters to $300 from $320 and keeps an In Line rating on the shares in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT: